Drugs / Human papillomavirus quadrivalent vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00677677 | May 2008 → Apr 2011 | disease related to transplantation | University of Alberta | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Human papillomavirus quadrivalent vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00677677 ↗ |
| Known as | quadrivalent HPV vaccine | “Patients were immunized with three doses of quadrivalent HPV vaccine containing viral types 6, 11, 16 and 18.” PMID 23837399 ↗ Jul 2013 |
| Modality | Vaccine | “Patients were immunized with three doses of quadrivalent HPV vaccine containing viral types 6, 11, 16 and 18.” PMID 23837399 ↗ Jul 2013 |
| Route | Intramuscular | “It is administered by intramuscular injection in three doses at 0, 2 months, and 6 months” NCT00677677 ↗ |